These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy. Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608 [TBL] [Abstract][Full Text] [Related]
45. Paraneoplastic pemphigus as a presentation of acute myeloid leukemia: Early diagnosis and remission. Siddiqui S; Bilal M; Otaibi Z; Bilimoria F; Patel N; Rossetti J Hematol Oncol Stem Cell Ther; 2017 Sep; 10(3):155-160. PubMed ID: 27352260 [TBL] [Abstract][Full Text] [Related]
46. Retrospective analysis of 45 cases of localized retroperitoneal Castleman disease from a single center. Tang JQ; Chen HK; Wang X; Wang MY; Xiong Y; Wang H; Yang YM Hepatobiliary Surg Nutr; 2020 Jun; 9(3):304-311. PubMed ID: 32509816 [TBL] [Abstract][Full Text] [Related]
47. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report. Li P; Liu H; Li H; Li A; Yu G; Yin W Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137 [TBL] [Abstract][Full Text] [Related]
48. Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa. Kim JH; Kim SC Front Immunol; 2019; 10():1259. PubMed ID: 31214197 [TBL] [Abstract][Full Text] [Related]
50. Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study. Yu T; Cai QQ; Zhai QL; Li L; Fang X; Li J; Sun R; Yang H; Wang Z; Qian W; Xu-Monette ZY; Young KH; Yu L Leuk Lymphoma; 2022 Dec; 63(13):3082-3091. PubMed ID: 36074798 [TBL] [Abstract][Full Text] [Related]
51. Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris. Miltenyi Z; Toth J; Gonda A; Tar I; Remenyik E; Illes A Pathol Oncol Res; 2009 Sep; 15(3):375-81. PubMed ID: 19067241 [TBL] [Abstract][Full Text] [Related]
52. Paraneoplastic pemphigus in association with Castleman's disease. Nikolskaia OV; Nousari CH; Anhalt GJ Br J Dermatol; 2003 Dec; 149(6):1143-51. PubMed ID: 14674890 [TBL] [Abstract][Full Text] [Related]
53. [Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck]. Gironet N; De Muret A; Machet L; Diot P; Rivollier C; Dumont P; Lorette G; Vaillant L Ann Dermatol Venereol; 2005 Jan; 132(1):41-4. PubMed ID: 15746607 [TBL] [Abstract][Full Text] [Related]
54. Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience. Wang J; Zhang Y; Pan M Dermatol Ther; 2020 Nov; 33(6):e14353. PubMed ID: 32990359 [TBL] [Abstract][Full Text] [Related]
55. A Rare Lymphoproliferative Disease: Castleman Disease. Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151 [TBL] [Abstract][Full Text] [Related]
56. Paraneoplastic Pemphigus with Underlying Castleman's Disorder: A Rare Report with Literature Review. Bin Waqar SH; Khan AA; Mohiuddin O; Rehan A Cureus; 2019 Jun; 11(6):e5022. PubMed ID: 31501721 [TBL] [Abstract][Full Text] [Related]
57. Paraneoplastic pemphigus associated with Castleman disease: progression from mucous to mucocutaneous lesions with epitope-spreading phenomena. Okahashi K; Oiso N; Ishii N; Miyake M; Uchida S; Matsuda H; Kitano M; Hida J; Kawai S; Sano A; Hashimoto T; Kawada A Br J Dermatol; 2017 May; 176(5):1406-1409. PubMed ID: 28213962 [No Abstract] [Full Text] [Related]
58. Multicentric Castleman disease of hyaline‑vascular variant with paraneoplastic pemphigus results in abnormal lung function: Report of 3 cases. Cen J; Zeng W; Pan M; Qiu Y; Zhang J Exp Ther Med; 2023 Jun; 25(6):269. PubMed ID: 37206548 [TBL] [Abstract][Full Text] [Related]
59. Prognostic factors of paraneoplastic pemphigus. Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794 [TBL] [Abstract][Full Text] [Related]
60. Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy. Materna-Kiryluk A; Pollak A; Gawalski K; Szczawinska-Poplonyk A; Rydzynska Z; Sosnowska A; Cukrowska B; Gasperowicz P; Konopka E; Pietrucha B; Grzywa TM; Banaszak-Ziemska M; Niedziela M; Skalska-Sadowska J; Stawiński P; Śladowski D; Nowis D; Ploski R Hum Mol Genet; 2021 Apr; 30(3-4):226-233. PubMed ID: 33517393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]